During the past decade, Recherche Sepmus, Inc. conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 8 clinical trials were completed, i.e. on average, 47.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 5 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Recherche Sepmus, Inc." #1 sponsor was "Hoffmann-La Roche" with 11 trials, followed by "Mitsubishi Tanabe Pharma America Inc." with 3 trials sponsored, "Actelion" with 1 trials sponsored, "Atara Biotherapeutics" with 1 trials sponsored and "Biogen" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Recherche Sepmus, Inc." #1 collaborator was "Bayer" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Recherche Sepmus, Inc." are "Multiple Sclerosis" (5 trials), "Multiple Sclerosis, Primary Progressive" (3 trials), "Multiple Sclerosis, Relapsing-Remitting" (3 trials), "ALS" (2 trials) and "Relapsing Multiple Sclerosis" (2 trials). Many other conditions were trialed in "Recherche Sepmus, Inc." in a lesser frequency.

Most popular intervention types in "Recherche Sepmus, Inc." are "Drug" (19 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (10 trials), "Placebo" (9 trials), "MT-1186" (3 trials), "Fenebrutinib" (2 trials) and "ATA188" (1 trials). Other intervention names were less common.

The vast majority of trials in "Recherche Sepmus, Inc." are 21 trials for "All" genders.

Currently, there are NaN active trials in "Recherche Sepmus, Inc.". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Recherche Sepmus, Inc., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Recherche Sepmus, Inc., 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".